Early detection of prostate cancer: Attention men, your health counts!

Early detection of prostate cancer: Attention men, your health counts!

Prostate cancer is the most common cancer in men and poses a serious health risk. In Austria, more than 7,500 men are diagnosed every year, although there are usually no symptoms in the early stages. Detecting the tumor in a timely manner is crucial as it significantly improves the chances of recovery. Experts emphasize that the most important risk factor is age, with incidence increasing with age. Men with a family history of the disease, such as affected fathers or brothers, also have an increased risk of the disease. Years of studies, such as the European Randomized Study of Screening for Prostate Cancer (ERSPC), show the importance of early detection and have led to standardized recommendations.

As the crown According to reports, experts point out that benign prostate enlargements can cause symptoms such as frequent urination or a weak urine stream, while prostate cancer often goes unnoticed. The PSA blood test is considered the most important measure for early detection. In light of the current discussions, professional associations recommend that men aged 45 and over regularly visit a urologist. An elevated PSA level is a warning sign, but not definitive evidence of cancer.

Early detection and statutory programs

The statutory cancer screening program includes an annual digital rectal examination (DRE) for men aged 45 and over, which is free of charge. This examination includes a discussion about complaints, an examination of the sexual organs and lymph nodes and a palpation of the prostate. However, the benefit of DRE is limited because usually only larger, superficial tumors can be detected. Additionally, the PSA test used to assess risk is not part of the statutory program, must be privately funded and has its own challenges. About 50 percent of tumors discovered cause no symptoms, leading to concerns about overdiagnosis.

Again Cancer Society Notes, if the PSA value is below 1 ng/ml, a check every 4 years is recommended, while if the PSA value is above 2 ng/ml, annual checks are necessary. Men over 70 years of age with a value below 1 ng/ml should no longer undergo PSA-based screening. If findings are suspicious, additional tests such as magnetic resonance imaging (MRI) or a tissue sample may need to be considered, although the latter can be painful.

Risks and Recommendations

Experts disagree about the best approach to early detection of prostate cancer. The benefits must be weighed against the risks of overdiagnosis - for example, that many tumors discovered pose potential risks but do not cause symptoms. According to the Cancer Information Service Statistics show that out of 10,000 men who undergo screening, only 12 are saved from death, while 49 still die from prostate cancer. In the context of this data, informative advice from the doctor is essential. Relatives, especially women, can motivate men to have a timely examination.

Regular check-ups are the key to optimal health care. The combination of medical assessment and informed decisions about screening measures can make a significant contribution to improving the chances of a long and healthy life. Prevention is essential to minimize the risk of a late diagnosis.